Considerations for management of patients with diabetes mellitus and acute COVID-19.

Mougakou, Efterpi; Kyziroglou, Maria; Tsankof, Alexandra; Cholongitas, Evangelos; Tziomalos, Konstantinos

Mougakou, Efterpi; Kyziroglou, Maria; Tsankof, Alexandra; Cholongitas, Evangelos; Tziomalos, Konstantinos.

Afiliação

Mougakou E; First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens 11527, Greece.
Kyziroglou M; First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece.
Tsankof A; First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece.
Cholongitas E; First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens 11527, Greece.
Tziomalos K; First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece. ktziomalos@yahoo.com.

World J Diabetes ; 13(10): 802-808, 2022 Oct 15.

Article em En | MEDLINE | ID: mdl-36312003

Palavras-chave

Antidiabetic agents; COVID-19; Dexamethasone; Diabetes mellitus; Insulin; Remdesivir; Tocilizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Diabetes Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google